Back to search

Netherlands· NL-86e051dff223

Melfalan Eugia 50 mg, poeder en oplosmiddel voor oplossing voor injectie of infusie

A melphalan product containing melfalanhydrochloride, registered in Netherlands by Eugia Pharma (Malta) Limited. The same ATC class is registered in 17 of our 19 countries.

ATC L01AA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMelfalan Eugia 50 mg, poeder en oplos…ATCL01AA03REGISTER NO.NL-86e051dff223PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Melphalan is registered in 17 of 19 countries.

Countries holding a registration under ATC L01AA03 (melphalan), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Melphalan · ATC L01AA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of melphalan costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.79 in Italy to $3.83 in Switzerland — a ×4.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Melphalan · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.83
  • FR France$0.89
  • IT Italy$0.79
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MELFALANHYDROCHLORIDE
Manufacturer
Eugia Pharma (Malta) Limited
Country
Netherlands (NL)
ATC code
L01AA03
ATC class
Melphalan
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131386

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

242 interactions on record for melphalan.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Melphalan · interactions on record

242 records

  • 32 severe
  • 100 moderate
  • 25 minor
  • 85 info

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • ThiotepaL01AC01severe
  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Melphalan in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All melphalan products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Alkeran, Melphalan Hikma
  • Belgium · Alkeran, Melfalan Tillomed
  • Cyprus · Melfalan Tillomed
  • Czechia · Alkeran, Melphalan Zentiva
  • Germany · Alkeran, Melphalan
  • Denmark · Alkeran, Melphalan Macure
  • Estonia · Alkeran
  • Spain · Alkeran, Melfalán Aspen
  • Finland · Alkeran, Melphalan Macure
  • France · Alkeran, Melphalan Hikma
  • United Kingdom (Northern Ireland) · Melphalan, Melphalan Accord-Uk
  • Greece · Demephan, Melphalan Tillomed
  • Croatia · Melfalan Pliva, Melfalan Tillomed
  • Hungary · Melphalan Teva, Melphalan Zentiva
  • Ireland · Alkeran, Melphalan Tillomed
  • Iceland · Alkeran, Phelinun
  • Italy · Alkeran, Melfalan Hikma
  • Liechtenstein · Phelinun
  • Lithuania · Alkeran, Melphalan Zentiva
  • Luxembourg · Alkeran, Melphalan Aqvida
  • Latvia · Alkeran, Melphalan Tillomed
  • Norway · Alkeran, Melphalan Macure
  • Poland · Alkeran, Melphalan Zentiva
  • Portugal · Alkeran, Melfalano Eugia
  • Romania · Alkeran, Melfalan Teva
  • Sweden · Alkeran, Melfalan Sun
  • Slovenia · Alkeran, Melfalan Teva
  • Slovakia · Alkeran, Melphalan Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9371fc84-97af-43d4-a91e-bf8966285c74
GET /v1/drugs/9371fc84-97af-43d4-a91e-bf8966285c74?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Intraveneus gebruik, Intra-arterieel gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131386_smpc_en.pdf",
  "strength": null,
  "atc_label": "Melphalan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131386",
  "excipients": [
    "ETHANOL 96 %",
    "POVIDON K 12 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "MELFALANHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131386_piluk.pdf",
  "authorised_at": "2024/10/09",
  "procedure_number": "PT/H/2505/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131386",
  "additional_monitoring": "N"
}

See everything about melphalan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.